In patients with systemic sclerosis, a rare but severe rheumatic disease characterized by Raynaud’s phenomenon, inflammation and fibrosis of skin, blood vessels and internal organs, the expanded CD21–/low cells are CD38low, and half of them are CD11c+ and switched [41, 42, 71]. Here, ITGAX is linked to rheumatic disorder.